{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T13:06:47Z","timestamp":1776085607904,"version":"3.50.1"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T00:00:00Z","timestamp":1773705600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012479","name":"General Research Fund of Shanghai Normal University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012479","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002920","name":"University Grants Committee Research Grants Council","doi-asserted-by":"publisher","award":["17106719"],"award-info":[{"award-number":["17106719"]}],"id":[{"id":"10.13039\/501100002920","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Schizophrenia Research"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.schres.2026.03.008","type":"journal-article","created":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T21:43:44Z","timestamp":1773870224000},"page":"88-95","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Ten-year risk prediction models for atherosclerotic cardiovascular disease in Chinese patients with schizophrenia-spectrum disorders: A population-based cohort study"],"prefix":"10.1016","volume":"292","author":[{"given":"Jennifer Yee-Man","family":"Tang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gloria Hoi-Yan","family":"Wong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huiquan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiayi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gary Kui Kai","family":"Lau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edwin Ho-Ming","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Terry Yat-Sang","family":"Lum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian Chi-Kei","family":"Wong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.schres.2026.03.008_bb0005","first-page":"e596","article-title":"2019 ACC\/AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology\/American Heart Association task force on clinical practice guidelines","volume":"140","author":"Arnett","year":"2019","journal-title":"Circulation"},{"issue":"21","key":"10.1016\/j.schres.2026.03.008_bb0010","doi-asserted-by":"crossref","first-page":"2714","DOI":"10.1002\/sim.8570","article-title":"Graphical calibration curves and the integrated calibration index (ICI) for survival models","volume":"39","author":"Austin","year":"2020","journal-title":"Stat. Med."},{"issue":"3","key":"10.1016\/j.schres.2026.03.008_bb0015","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s40261-019-00751-2","article-title":"Association of first- vs. second-generation antipsychotics with lipid abnormalities in individuals with severe mental illness: a systematic review and meta-analysis","volume":"39","author":"Buhagiar","year":"2019","journal-title":"Clin. Drug Investig."},{"issue":"2","key":"10.1016\/j.schres.2026.03.008_bb0020","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S2215-0366(20)30004-3","article-title":"Risk of self-harm after the diagnosis of psychiatric disorders in Hong Kong, 2000-10: a nested case-control study","volume":"7","author":"Chai","year":"2020","journal-title":"Lancet Psychiatry"},{"issue":"7","key":"10.1016\/j.schres.2026.03.008_bb0025","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1093\/jnci\/djx267","article-title":"Aspirin and risk of gastric cancer after helicobacter pylori eradication: a territory-wide study","volume":"110","author":"Cheung","year":"2018","journal-title":"J. Natl. Cancer Inst."},{"issue":"11","key":"10.1016\/j.schres.2026.03.008_bb0030","doi-asserted-by":"crossref","first-page":"786","DOI":"10.7326\/M16-1739","article-title":"Calibration of the pooled cohort equations for atherosclerotic cardiovascular disease: an update","volume":"165","author":"Cook","year":"2016","journal-title":"Ann. Intern. Med."},{"issue":"2","key":"10.1016\/j.schres.2026.03.008_bb0035","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1002\/wps.20994","article-title":"Mortality in people with schizophrenia: a systematic review and meta-analysis of relative risk and aggravating or attenuating factors","volume":"21","author":"Correll","year":"2022","journal-title":"World Psychiatry"},{"issue":"9","key":"10.1016\/j.schres.2026.03.008_bb0040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0221521","article-title":"Prediction of cardiovascular disease risk among people with severe mental illness: a cohort study","volume":"14","author":"Cunningham","year":"2019","journal-title":"PloS One"},{"issue":"1","key":"10.1016\/j.schres.2026.03.008_bb0045","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s12916-019-1340-7","article-title":"Performance of the Framingham risk models and pooled cohort equations for predicting 10-year risk of cardiovascular disease: a systematic review and meta-analysis","volume":"17","author":"Damen","year":"2019","journal-title":"BMC Med."},{"issue":"2","key":"10.1016\/j.schres.2026.03.008_bb0050","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/nrendo.2011.156","article-title":"Metabolic and cardiovascular adverse effects associated with antipsychotic drugs","volume":"8","author":"De Hert","year":"2011","journal-title":"Nat. Rev. Endocrinol."},{"issue":"19","key":"10.1016\/j.schres.2026.03.008_bb0055","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","article-title":"Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III)","volume":"285","author":"Expert Panel on Detection, E","year":"2001","journal-title":"JAMA"},{"issue":"9","key":"10.1016\/j.schres.2026.03.008_bb0060","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.jacc.2022.06.017","article-title":"Severe mental illness and cardiovascular disease: JACC state-of-the-art review","volume":"80","author":"Goldfarb","year":"2022","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.schres.2026.03.008_bb0065","article-title":"Development and validation of QRISK3 risk prediction algorithms to estimate future risk of cardiovascular disease: prospective cohort study","volume":"357","author":"Hippisley-Cox","year":"2017","journal-title":"BMJ"},{"issue":"3","key":"10.1016\/j.schres.2026.03.008_bb0070","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.genhosppsych.2015.03.004","article-title":"Review of the evidence: prevalence of medical conditions in the United States population with serious mental illness","volume":"37","author":"Janssen","year":"2015","journal-title":"Gen. Hosp. Psychiatry"},{"issue":"9","key":"10.1016\/j.schres.2026.03.008_bb0075","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0024597","article-title":"Chronic somatic comorbidity and excess mortality due to natural causes in persons with schizophrenia or bipolar affective disorder","volume":"6","author":"Laursen","year":"2011","journal-title":"PloS One"},{"issue":"2","key":"10.1016\/j.schres.2026.03.008_bb0080","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/YCO.0b013e32835035ca","article-title":"Life expectancy and cardiovascular mortality in persons with schizophrenia","volume":"25","author":"Laursen","year":"2012","journal-title":"Curr. Opin. Psychiatry"},{"issue":"3","key":"10.1016\/j.schres.2026.03.008_bb0085","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1161\/CIRCULATIONAHA.114.008779","article-title":"Association between antipsychotic use and risk of acute myocardial infarction: a nationwide case-crossover study","volume":"130","author":"Lin","year":"2014","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.schres.2026.03.008_bb0090","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1093\/schbul\/sbs082","article-title":"Is the prevalence of metabolic syndrome and metabolic abnormalities increased in early schizophrenia? A comparative meta-analysis of first episode, untreated and treated patients","volume":"39","author":"Mitchell","year":"2013","journal-title":"Schizophr. Bull."},{"issue":"2","key":"10.1016\/j.schres.2026.03.008_bb0095","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/s41569-020-00463-7","article-title":"Cardiovascular disease in patients with severe mental illness","volume":"18","author":"Nielsen","year":"2021","journal-title":"Nat. Rev. Cardiol."},{"issue":"12","key":"10.1016\/j.schres.2026.03.008_bb0100","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1001\/jamapsychiatry.2015.1737","article-title":"Premature mortality among adults with schizophrenia in the United States","volume":"72","author":"Olfson","year":"2015","journal-title":"JAMA Psychiatry"},{"issue":"2\u20133","key":"10.1016\/j.schres.2026.03.008_bb0105","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.schres.2011.04.003","article-title":"Inequalities in the provision of cardiovascular screening to people with severe mental illnesses in primary care: cohort study in the United Kingdom THIN primary care database 2000\u20132007","volume":"129","author":"Osborn","year":"2011","journal-title":"Schizophr. Res."},{"issue":"2","key":"10.1016\/j.schres.2026.03.008_bb0110","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1001\/jamapsychiatry.2014.2133","article-title":"Cardiovascular risk prediction models for people with severe mental illness: results from the prediction and management of cardiovascular risk in people with severe mental illnesses (PRIMROSE) research program","volume":"72","author":"Osborn","year":"2015","journal-title":"JAMA Psychiatry"},{"issue":"6","key":"10.1016\/j.schres.2026.03.008_bb0115","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1161\/CIRCULATIONAHA.120.052430","article-title":"Quantifying and understanding the higher risk of atherosclerotic cardiovascular disease among South Asian individuals: results from the UK Biobank prospective cohort study","volume":"144","author":"Patel","year":"2021","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.schres.2026.03.008_bb0120","doi-asserted-by":"crossref","DOI":"10.1192\/bjo.2019.76","article-title":"Health screening, cardiometabolic disease and adverse health outcomes in individuals with severe mental illness","volume":"5","author":"Pearsall","year":"2019","journal-title":"BJPsych Open"},{"issue":"1","key":"10.1016\/j.schres.2026.03.008_bb0125","doi-asserted-by":"crossref","DOI":"10.1136\/bmjment-2022-300501","article-title":"Associations between antipsychotics and the risk of incident cardiovascular diseases in individuals with schizophrenia: a nested case-control study","volume":"26","author":"Peng","year":"2023","journal-title":"BMJ Ment Health"},{"key":"10.1016\/j.schres.2026.03.008_bb0130","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.eurpsy.2016.02.004","article-title":"Cardiovascular risk factors among patients with schizophrenia, bipolar, depressive, anxiety, and personality disorders","volume":"35","author":"Perez-Pinar","year":"2016","journal-title":"Eur. Psychiatry"},{"issue":"2","key":"10.1016\/j.schres.2026.03.008_bb0135","doi-asserted-by":"crossref","DOI":"10.3390\/ph17020178","article-title":"Antipsychotics and risks of cardiovascular and cerebrovascular diseases and mortality in dwelling community older adults","volume":"17","author":"Perreault","year":"2024","journal-title":"Pharmaceuticals (Basel)"},{"issue":"5","key":"10.1016\/j.schres.2026.03.008_bb0140","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1517\/14740338.2016.1161021","article-title":"Cardiovascular safety of antipsychotics: a clinical overview","volume":"15","author":"Polcwiartek","year":"2016","journal-title":"Expert Opin. Drug Saf."},{"key":"10.1016\/j.schres.2026.03.008_bb0145","article-title":"External validation of clinical prediction models using big datasets from e-health records or IPD meta-analysis: opportunities and challenges","volume":"353","author":"Riley","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.schres.2026.03.008_bb0150","first-page":"137","article-title":"Increased mortality in schizophrenia due to cardiovascular disease - a non-systematic review of epidemiology, possible causes, and interventions","volume":"5","author":"Ringen","year":"2014","journal-title":"Front. Psych."},{"issue":"1","key":"10.1016\/j.schres.2026.03.008_bb0155","doi-asserted-by":"crossref","first-page":"9","DOI":"10.5334\/ijic.2605","article-title":"Integrated care to address the physical health needs of people with severe mental illness: a mapping review of the recent evidence on barriers, facilitators and evaluations","volume":"18","author":"Rodgers","year":"2018","journal-title":"Int. J. Integr. Care"},{"issue":"4","key":"10.1016\/j.schres.2026.03.008_bb0160","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s40261-021-01000-1","article-title":"Second-generation antipsychotic drugs for patients with schizophrenia: systematic literature review and meta-analysis of metabolic and cardiovascular side effects","volume":"41","author":"Rognoni","year":"2021","journal-title":"Clin. Drug Investig."},{"issue":"Pt 1","key":"10.1016\/j.schres.2026.03.008_bb0165","first-page":"293","article-title":"A territory-wide electronic health record--from concept to practicality: the Hong Kong experience","volume":"129","author":"Sek","year":"2007","journal-title":"Stud. Health Technol. Inform."},{"issue":"3","key":"10.1016\/j.schres.2026.03.008_bb0170","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1590\/1806-9282.63.03.261","article-title":"Association between antipsychotics and cardiovascular adverse events: a systematic review","volume":"63","author":"Silva","year":"2017","journal-title":"Rev. Assoc. Med. Bras. (1992)"},{"issue":"25 Suppl 2","key":"10.1016\/j.schres.2026.03.008_bb0175","first-page":"S1","article-title":"2013 ACC\/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology\/American Heart Association task force on practice guidelines","volume":"129","author":"Stone","year":"2014","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.schres.2026.03.008_bb0180","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0166429","article-title":"High prevalence of obesity, hypertension, hyperlipidemia, and diabetes mellitus in Japanese outpatients with schizophrenia: a nationwide survey","volume":"11","author":"Sugai","year":"2016","journal-title":"PloS One"},{"issue":"1","key":"10.1016\/j.schres.2026.03.008_bb0185","doi-asserted-by":"crossref","DOI":"10.1186\/1472-6963-5-31","article-title":"Under-reporting of inpatient services utilisation in household surveys \u2014 a population-based study in Hong Kong","volume":"5","author":"Tsui","year":"2005","journal-title":"BMC Health Serv. Res."},{"issue":"3","key":"10.1016\/j.schres.2026.03.008_bb0190","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1002\/wps.20069","article-title":"A meta-analysis of cardio-metabolic abnormalities in drug naive, first-episode and multi-episode patients with schizophrenia versus general population controls","volume":"12","author":"Vancampfort","year":"2013","journal-title":"World Psychiatry"},{"issue":"13","key":"10.1016\/j.schres.2026.03.008_bb0195","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1017\/S0033291717000873","article-title":"Antipsychotic medication and long-term mortality risk in patients with schizophrenia; a systematic review and meta-analysis","volume":"47","author":"Vermeulen","year":"2017","journal-title":"Psychol. Med."},{"issue":"18","key":"10.1016\/j.schres.2026.03.008_bb0200","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1161\/01.CIR.97.18.1837","article-title":"Prediction of coronary heart disease using risk factor categories","volume":"97","author":"Wilson","year":"1998","journal-title":"Circulation"},{"issue":"19","key":"10.1016\/j.schres.2026.03.008_bb0205","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1161\/CIRCULATIONAHA.116.022367","article-title":"Predicting the 10-year risks of atherosclerotic cardiovascular disease in Chinese population: the China-PAR project (prediction for ASCVD risk in China)","volume":"134","author":"Yang","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.schres.2026.03.008_bb0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajp.2024.104315","article-title":"The reliability of medication and death recording in electronic health records among people with schizophrenia in Hong Kong","volume":"103","author":"Zhou","year":"2025","journal-title":"Asian J. Psychiatr."},{"issue":"9","key":"10.1016\/j.schres.2026.03.008_bb0215","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-018181","article-title":"Effectiveness and cost-effectiveness of a cardiovascular risk prediction algorithm for people with severe mental illness (PRIMROSE)","volume":"7","author":"Zomer","year":"2017","journal-title":"BMJ Open"}],"container-title":["Schizophrenia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996426000836?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996426000836?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T12:30:52Z","timestamp":1776083452000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920996426000836"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":43,"alternative-id":["S0920996426000836"],"URL":"https:\/\/doi.org\/10.1016\/j.schres.2026.03.008","relation":{},"ISSN":["0920-9964"],"issn-type":[{"value":"0920-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ten-year risk prediction models for atherosclerotic cardiovascular disease in Chinese patients with schizophrenia-spectrum disorders: A population-based cohort study","name":"articletitle","label":"Article Title"},{"value":"Schizophrenia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.schres.2026.03.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}